Berlin Institute for Health Research

from Wikipedia, the free encyclopedia
Berlin Institute for Health Research
Berlin Institute for Health Research
Logo of the Berlin Institute for Health Research
Category: research Institute
Legal form of the carrier: Public corporation
Facility location: Berlin-Mitte: Anna-Louisa-Karsch-Strasse 2
Type of research: Basic research , clinical research
Subjects: Life sciences , medicine
Basic funding: Federal Government (90%), State of Berlin (10%)
Homepage: www.bihealth.org

The Berlin Institute for Health Research ( Berlin Institute of Health , BIH) is a scientific institution for translational and precision medicine. The BIH is dedicated to new approaches for better predictions and novel therapies for progressive diseases in order to restore or maintain people's quality of life. With top translational research and innovations, the BIH is paving the way for benefit-oriented, personalized healthcare . The founding institutions Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) are independent member bodies in the BIH.

history

Since the MDC was founded in 1992, the MDC and Charité have been working together on individual or joint projects. In July 2011, the two institutions signed an agreement for cooperation (Memorandum of Understanding) in the form of a joint institution. In November 2012, the planned re-establishment of the federal and state governments was announced to the public. Two months later, the federal government and the state of Berlin sealed the administrative agreement for the "establishment, organization and financing of the Berlin Institute for Health Research". On March 25, 2013, the Charité - Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine, the Federal Ministry of Education and Research , the Senate Department for Education, Youth and Science Berlin and the Helmholtz Association of German Research Centers signed the founding agreement. The institute was founded as an indoor GbR. Since April 23, 2015 it has been a legally competent and independent corporation under public law (§ 1 BIGG).

With the institute, a university medicine facility and a non-university research facility were merged into a separate institution (corporation under public law) for the first time in Germany. Both institutions, Charité and MDC, remain independent member bodies.

organization

The Berlin Institute for Health Research is headed by a board of directors (Section 6 BIGG). The board is responsible for the strategic planning and implementation of the research program. The members are:

The office (based in Berlin-Mitte) supports the board in planning and implementing the strategy and the research program. As the highest body, a supervisory board monitors all activities of the institute. He is responsible for decisions with far-reaching relevance (e.g. business plan, strategic planning, appointment planning and major investments). A scientific advisory board advises the board of directors and the supervisory board on scientific-strategic issues. Members of the advisory board are international experts in translational research and systems medicine.

research

The scientific concept of the Berlin Institute for Health Research comprises five central goals:

  • Strengthening systems medicine research
  • Establishment of translational organizational units
  • Development and expansion of infrastructures and technology platforms
  • Development of new career paths (promotion of young talent)
  • Recruiting internationally outstanding scientists

Translational organizational units

In order to create excellent framework conditions for patient-oriented research and clinical studies, a Clinical Research Unit (CRU) is being established at the institute at the Charité locations in Buch, Benjamin Franklin, Mitte and Virchow-Klinikum. There, scientists and doctors work hand in hand from basic research to initial clinical studies. The CRU combines laboratories and treatment centers in one place. At the same time, it is separated from the regular outpatient and inpatient clinic areas. Here, subjects and patients are looked after as part of research-initiated clinical or experimental studies outside of standard care.

Research infrastructure

The Berlin Institute for Health Research is developing and expanding infrastructures and technology platforms (core facilities) in both the experimental and clinical areas in order to create the technological prerequisites for systems medicine-oriented, cooperative research.

The institute's omics platform specializes in high-throughput technologies and the processing and analysis of clinical samples. A genomics center with modern equipment for next-generation sequencing as well as a proteomics and metabolomics unit, equipped with the latest mass spectrometers, will be built . The bioinformatic expertise required to evaluate systems medical and clinical data will be established under the umbrella of the BIH Center of Bioinformatics. The computing capacities required for scientific computing are housed in a dedicated computing center on the Buch campus. Service units are established on other technology platforms and our own research work is carried out, for example stem cells , medical imaging processes, transgenic techniques and chemical biology (in cooperation with the Leibniz Institute for Molecular Pharmacology).

Promotion of young talent

A new generation of translationally oriented scientists will be trained at the Berlin Institute for Health Research. These education and training programs are combined under the umbrella of the BIH Biomedical Academy. The spectrum of activities includes scholarships / grants as well as training offers for students, doctoral candidates and postdocs and advanced training for medical specialists.

financing

The Berlin Institute for Health Research is financed at a ratio of 90:10 (federal: state). The entrepreneur and founder of the Charité Foundation , Johanna Quandt , is also supporting the establishment of the institute with a total of up to 40 million euros over the next ten years with a “private excellence initiative” . These funds are administered by the Charité Foundation.

Web links

Individual evidence

  1. ↑ Anne Brüning: Berlin as the capital of medicine: Berlin researchers explore Alzheimer's and cancer therapies. January 18, 2015, accessed on November 6, 2019 (German).
  2. ↑ Berlin clears the way for a new institute. Retrieved November 6, 2019 . Article in the Ärzte-Zeitung of April 7, 2015 on the passing of the law on the Berlin Institute for Health Research in the Berlin House of Representatives
  3. ↑ Andreas Abel: Berlin wants to be in the front row when it comes to cutting-edge research. January 22, 2015, accessed on November 6, 2019 (German).

Coordinates: 52 ° 31 '12.9 "  N , 13 ° 24' 5.9"  E